D'Ugo, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 5.497
AS - Asia 5.024
EU - Europa 4.494
SA - Sud America 1.101
AF - Africa 148
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.285
Nazione #
US - Stati Uniti d'America 5.340
SG - Singapore 2.468
DE - Germania 1.358
CN - Cina 1.247
BR - Brasile 928
SE - Svezia 765
IT - Italia 714
FR - Francia 330
UA - Ucraina 304
IN - India 298
GB - Regno Unito 255
VN - Vietnam 251
IE - Irlanda 231
ID - Indonesia 163
RU - Federazione Russa 111
TR - Turchia 106
FI - Finlandia 93
HK - Hong Kong 91
AR - Argentina 80
CA - Canada 79
BD - Bangladesh 64
KR - Corea 60
JP - Giappone 58
PL - Polonia 57
NL - Olanda 51
MX - Messico 50
IQ - Iraq 46
AT - Austria 44
ES - Italia 42
ZA - Sudafrica 38
BE - Belgio 32
CI - Costa d'Avorio 25
EC - Ecuador 24
MA - Marocco 20
PK - Pakistan 19
VE - Venezuela 19
CZ - Repubblica Ceca 16
LT - Lituania 16
SA - Arabia Saudita 16
UZ - Uzbekistan 14
CL - Cile 13
IR - Iran 13
KE - Kenya 13
PE - Perù 12
RO - Romania 12
AZ - Azerbaigian 11
IL - Israele 11
JO - Giordania 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 9
ET - Etiopia 9
GR - Grecia 9
CO - Colombia 8
DK - Danimarca 8
EG - Egitto 8
AU - Australia 7
BO - Bolivia 7
DZ - Algeria 7
NP - Nepal 7
TH - Thailandia 7
KG - Kirghizistan 6
LB - Libano 6
LV - Lettonia 6
PY - Paraguay 6
SN - Senegal 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
PA - Panama 5
PH - Filippine 5
PS - Palestinian Territory 5
PT - Portogallo 5
AM - Armenia 4
BY - Bielorussia 4
CY - Cipro 4
EU - Europa 4
MD - Moldavia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
EE - Estonia 3
HN - Honduras 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
OM - Oman 3
RS - Serbia 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
CG - Congo 2
JM - Giamaica 2
LU - Lussemburgo 2
LY - Libia 2
NA - Namibia 2
NG - Nigeria 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
Totale 16.262
Città #
Singapore 1.125
Chandler 1.049
Ashburn 529
Beijing 269
Dublin 228
Los Angeles 190
San Mateo 188
Hefei 181
Jacksonville 171
New York 165
Wilmington 152
Jakarta 149
Milan 138
Hyderabad 122
Nanjing 118
Rome 108
Ann Arbor 100
Ho Chi Minh City 97
Princeton 91
Hong Kong 90
São Paulo 88
Munich 79
Nürnberg 78
Frankfurt am Main 74
Chicago 67
Izmir 65
Moscow 65
Boston 64
Cattolica 64
Houston 64
Dearborn 62
Hanoi 57
Woodbridge 57
Seoul 56
Marseille 55
Dallas 52
Tokyo 52
Fairfield 47
Kent 45
Buffalo 43
Verona 43
Zhengzhou 41
Lancaster 40
Warsaw 40
Lawrence 39
Santa Clara 39
Brooklyn 38
Nuremberg 37
Seattle 37
Nanchang 36
Boardman 35
Bremen 35
Redwood City 34
The Dalles 33
Brussels 32
Norwalk 32
London 31
Mountain View 31
Rio de Janeiro 30
Shenyang 27
Chennai 26
Stockholm 26
Abidjan 25
Denver 24
Curitiba 23
Düsseldorf 23
Johannesburg 23
Montreal 23
San Francisco 23
Tianjin 23
Toronto 23
Amsterdam 22
Helsinki 22
Poplar 22
Atlanta 20
Belo Horizonte 20
Changsha 20
Hebei 19
Orem 19
Vienna 19
Brasília 18
Phoenix 18
Shanghai 17
Augusta 16
Baghdad 16
Cambridge 16
Dhaka 16
Lauterbourg 16
Campinas 15
Kunming 15
Leawood 15
Busto Arsizio 14
Hangzhou 14
Mumbai 14
Redmond 14
Turku 14
Charlotte 13
Falkenstein 13
Lappeenranta 13
Manchester 13
Totale 7.949
Nome #
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 412
NutriCatt protocol in the enhanced recovery after surgery (ERAS) program for colorectal surgery: the nutritional support improves clinical and cost-effectiveness outcomes. 234
A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression 227
The Road to Curative Surgery in Gastric Cancer Treatment: A Different Path in the Elderly? 226
Feasibility of discharge within 72 hours of major colorectal surgery: lessons learned after 5 years of institutional experience with the ERAS protocol 198
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 194
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 193
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 169
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 168
cDNA-Microarray Analysis as a New Tool to Predict Lymph Node Metastasis in Gastric Cancer 168
Education and imaging: gastrointestinal: videocapsule retention: rationale for surgical indication 163
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 157
R0 resection in the treatment of gastric cancer: room for improvement 149
Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer 148
Acute pancreatitis associated with primary hyperparathyroidism 146
Harlequin Syndrome 144
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 143
Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification system 141
Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives 141
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 139
Metastatic lymph node ratio: a new staging system for gastric cancer 139
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 139
3D pelvimetry and biometric measurements: a surgical perspective for colorectal resections 137
Transanal Total Mesorectal Excision vs Laparoscopic Total Mesolectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. 134
The learning curve of TaTME for mid-low rectal cancer: a comprehensive analysis from a five-year institutional experience 134
Large bowel auto-amputation and passage of a colon 'cast' after left hemicolectomy 133
Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients 133
The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review 133
Therapeutic implications of mesenchymal stem cells in liver injury 132
Determinants of surgical morbidity in gastric cancer treatment 132
Prognostic value of preoperative staging in gastric cancer 131
Prognostic Value of Preoperative Staging in Gastric Cancer 126
Preoperative treatment and surgery in gastric cancer: friends or foes? 126
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 123
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer 123
Surgery in COVID-19 patients: Operational directives 122
D1-plus vs D2 nodal dissection in gastric cancer: A propensity score matched comparison and review of published literature 121
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all 119
Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery 118
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy 117
Giant inflammatory polyposis as the first manifestation of inflammatory bowel disease 117
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 116
The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: A systematic review and meta-analysis of non-randomized, adjusted studies 116
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 116
Perioperative chemotherapy for gastric cancer: how should we measure the efficacy? 115
Impact of the COVID-19 Pandemic on Enhanced Recovery After Surgery (ERAS) Application and Outcomes: Analysis in the “Lazio Network” Database 114
Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse 114
The "Lazio Network" experience. The first Italian regional research group on the Enhanced Recovery After Surgery (ERAS) program. A collective database with 1200 patients in 2016-2017 113
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 113
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy 112
REGATTA trial: a call for the USA and Europe 111
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 111
Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? 110
Tumor size as a prognostic factor in patients with stage IIa colon cancer 110
Intraoperative esophageal manometry in surgical treatment of achalasia: a reappraisal. 105
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 105
Gastric cancer: Current status of lymph node dissection 104
Towards the goal of r0 resection in locally advanced gastriccancer through the path of neoadjuvant chemotherapy e impact of tumour downstaging on survival in a single series. 103
Limited lymph node dissection and metastatic lymph node ratio: a wave of trust 103
Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer 102
Follow-up: the evidence 101
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 98
The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer 97
Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse 97
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 97
Transesophageal echocardiographic assessment of hemodynamic function during laparoscopic cholecystectomy in healthy patients. 96
Italian multi-society modified Delphi consensus on the definition and management of anastomotic leakage in colorectal surgery 96
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 96
Nutricatt protocol improves body composition and clinical outcomes in elderly patients undergoing colorectal surgery in eras program: A retrospective cohort study 95
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 94
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 93
Quality Over Volume: Modeling Centralization of Gastric Cancer Resections in Italy 93
Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011 92
Krukenberg tumors: Seed, route and soil 92
Impact of Diagnostic laparoscopy on the managment of gastic cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma 91
Surgical issues after neoadjuvant treatment for gastric cancer 91
Association between colorectal cancer and streptococcus gallolyticus subsp. pasteuranus (former s. bovis) endocarditis: Clinical relevance and cues for microbiota science. case report and review of the literature 91
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 89
Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment 89
Image of the month--quiz case. 88
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 87
Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies. 86
The scintigraphic prediction of residual lung function after lobectomy in patients with bronchial carcinoma 86
Enhanced recovery after surgery (ERAS) program in octogenarian patients: a propensity score matching analysis on the "Lazio Network" database 85
Fashioning enterotomy closure after totally laparoscopic ileocolic anastomosis for right colon cancer: a multicenter experience 85
Open versus laparoscopic versus robotic gastric gastrointestinal stromal tumour resections: A multicentre cohort study 85
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 85
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 84
Synchronous gastric adenocarcinoma and MALT lymphoma in a patient with H. pylori infection. Could the two neoplasms share a common pathogenesis? 84
Beyond the Guidelines: The Grey Zones of the Management ofGastric Cancer. Consensus Statements from the Gastric CancerItalian Network (GAIN) 84
Totally laparoscopic right colectomy versus laparoscopically assisted right colectomy: a propensity score analysis 82
Thyroid cancer in suppressed contralateral lobe of patients with hot thyroid nodule 82
Clostridium difficile infection after stoma reversal surgery: a systematic review and meta-analysis of the literature 80
Profiling complete regression after pre-operative therapy in gastric cancer patients using clinical and pathological data 79
Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database 79
Prognostic Indicators in Stage IV Surgically Treated Gastric Cancer Patients: A Retrospective Multi-Institutional Study 79
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 77
The Use of Indocyanine Green (ICG) and Near-Infrared (NIR) Fluorescence-Guided Imaging in Gastric Cancer Surgery: A Narrative Review 77
Neoadjuvant chemotherapy and ongoing-trials 77
Neoadjuvant chemotherapy in gastric carcinoma 77
Totale 11.958
Categoria #
all - tutte 74.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021663 0 0 0 0 0 68 137 6 197 78 137 40
2021/20221.129 169 62 18 129 37 16 16 195 35 63 193 196
2022/20232.576 339 339 193 421 157 320 104 194 351 27 97 34
2023/20241.189 58 337 34 62 44 135 71 22 18 81 140 187
2024/20253.535 50 73 245 196 339 105 121 143 474 411 820 558
2025/20264.719 1.357 253 536 946 1.542 85 0 0 0 0 0 0
Totale 16.610